Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 02/29/16

ETCTN Program Leadership Contact Information

S. Percy Ivy, M.D.
ETCTN Program Director
ETCTN Phase 1 Science Officer
Associate Chief, Investigational Drug Branch
Cancer Therapy Evaluation Program
Division of Cancer Treatment and Diagnosis
ivyp@mail.nih.gov

Jeffrey Moscow, M.D.
ETCTN Phase 2 Science Officer
Medical Officer, Investigational Drug Branch
Cancer Therapy Evaluation Program
Division of Cancer Treatment and Diagnosis
moscowja@mail.nih.gov

James A. Zwiebel, M.D.
Chief, Investigational Drug Branch
Cancer Therapy Evaluation Program
Division of Cancer Treatment and Diagnosis
zwiebelj@mail.nih.gov

NCI Early Drug Development Opportunity Program (EDDOP) Contact Information

Jeffrey Moscow, M.D.
Early Drug Development Opportunity Program Coordinator
Medical Officer, Investigational Drug Branch
Cancer Therapy Evaluation Program
Division of Cancer Treatment and Diagnosis
moscowja@mail.nih.gov

Henry Ciolino, Ph.D.
Early Drug Development Opportunity Program Contact
Acting Director, NCI Office of Cancer Centers
Cancer Therapy Evaluation Program
Division of Cancer Treatment and Diagnosis
henry.ciolino@nih.gov